Page last updated: 2024-10-22

amitriptyline and Blepharospasm-Oromandibular Dyskinesia

amitriptyline has been researched along with Blepharospasm-Oromandibular Dyskinesia in 2 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Le Doze, F1
Moulin, M1
Defer, GL1
Gonzales, GR1

Other Studies

2 other studies available for amitriptyline and Blepharospasm-Oromandibular Dyskinesia

ArticleYear
Meige's syndrome in a patient treated with ranitidine.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:1

    Topics: Aged; Amitriptyline; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Humans; Meige Syndrome; R

1999
Postherpes simplex type 1 neuralgia simulating postherpetic neuralgia.
    Journal of pain and symptom management, 1992, Volume: 7, Issue:5

    Topics: Amitriptyline; Chronic Disease; Diagnosis, Differential; Female; Herpes Simplex; Herpes Zoster; Huma

1992